We found that overexpression of SAMD1 could reduce anti‐B2GPI and ACA levels, shorten aPTT, and increase PLT, thereby reversing APS‐induced vascular injury to some extent. Here, SAMD1 is linked to autoimmune polyendocrinopathy.